Submissions from 2023
Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy, C Sako, Brendan Curti, Roshanthi Weerasignhe, and See all authors in comments
Immune Pathway Antagonists, R Sanborn
Adjuvant/Neoadjuvant/Perioperative A (Whirlwind) Tour of Recent Developments in Early-Stage NSCLC, Rachel Sanborn
Does Finding a Rare Mutation Accomplish Anything, Rachel Sanborn
Personalizing Management of Early-Stage NSCLC. Sanborn R. APP Oncology Summit; 2023 October 8; Portland, OR., Rachel Sanborn
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn
The Role of SHP-2 Inhibitors Alone or in Combination, Rachel Sanborn
2166 / 8 - Analysis of ctDNA next generation sequencing (NGS) for predicting response to amivantamab and lazertinib among patients with EGFR-mutant NSCLC after progression on osimertinib and platinum-based chemotherapy (CHRYSALIS-2 Cohort A), Rachel E Sanborn and See full list of authors in comments
NSCLC with MET Amplification (METamp): Epidemiology, Disease Characteristics, Testing Procedures, and Economic and Humanistic Burden – a Targeted Literature Review, Rachel Sanborn and See all authors in comments
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn and See full list of authors in comments
Breast Cancer Immunology, SE Sanborn
Immunology 101, SE Sanborn
Age-related next-generation sequencing mutational analysis in 1196 melanomas., Juan A Santamaria-Barria, Chikako Matsuba, Adam Khader, Anthony J Scholar, Mary Garland-Kledzik, Trevan D Fischer, Richard Essner, Matthew P Salomon, Joshua M V Mammen, and Melanie Goldfarb
Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial., Inderpal S Sarkaria, Linda W Martin, David C Rice, Shanda H Blackmon, Herbert B Slade, Sunil Singhal, ELUCIDATE Study Group, and Brian Louie (ELUCIDATE Study Group)
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies., Gary J Schiller, Brea C Lipe, Nizar J Bahlis, Sascha A Tuchman, William I Bensinger, Heather J Sutherland, Suzanne Lentzsch, Muhamed Baljevic, Darrell White, Rami Kotb, Christine I Chen, Adriana Rossi, Noa Biran, Richard LeBlanc, Sebastian Grosicki, Maurizio Martelli, Eberhard Gunsilius, Ivan Špička, Don Ambrose Stevens, Thierry Facon, Mercedes Gironella Mesa, Chris Zhang, Dane R Van Domelen, Ohad S Bentur, and Cristina Gasparetto
Preoperative Treatment of Locally Advanced Rectal Cancer., Deborah Schrag, Qian Shi, Martin R Weiser, Marc J Gollub, Leonard B Saltz, Benjamin L Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn A Goodman, Robert R McWilliams, Jeffrey M Farma, Thomas J George, Hagen F Kennecke, Ardaman Shergill, Michael Montemurro, Garth D Nelson, Brian Colgrove, Vallerie Gordon, Alan P Venook, Eileen M O'Reilly, Jeffrey A Meyerhardt, Amylou C Dueck, Ethan Basch, George J Chang, and Harvey J Mamon
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048), D Schrag, HF Kennecke, and See all authors in comments
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis., Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishanan Sivaraman, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer., Shay Sharon, Narmeen Daher-Ghanem, Deema Zaid, Michael J Gough, and Nataly Kravchenko-Balasha
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B cell lymphoma., Geoffrey Shouse, Andy Kaempf, Max J Gordon, Andrew S Artz, David Yashar, Audrey M Sigmund, Gordon Smilnak, Steven M Bair, Agrima Mian, Lindsey A Fitzgerald, Amneet Bajwa, Samantha M Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M Stephens, Manali Kamdar, Brian T Hill, Jordan Gauthier, Reem Karmali, Loretta J Nastoupil, Adam S Kittai, and Alexey V Danilov
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma., Ann W Silk, Brendan Curti, Jennifer Bryan, Tracie Saunders, Weichung Shih, Michael P Kane, Phoebe Hannon, Christopher B Fountain, Jessica Felcher, Andrew Zloza, Howard L Kaufman, Janice M Mehnert, and David F McDermott
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC., George R. Simon, Brendan Curti, Roshanthi Weerasinghe, and See all authors in comments
Association of nutrition with psychological health and quality of life among older adults with advanced cancer, Surbhi Singhal, Alison Conlin, and See full list of authors in comments
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma., Meenal Sinha, Courtney Betts, Li Zhang, Madeline J Griffith, Isabelle Solman, Brandon Chen, Eric Liu, Whitney Tamaki, Jacob Stultz, Jaqueline Marquez, Shamilene Sivagnanam, Alexander Cheung, Denise Pener, Anne Fahlman, Erin Taber, Kimberly Lerner, Matthew Crocker, Kendra Todd, Brindha Rajagopalan, Clarisha Ware, Mark Bridge, Johnson Vo, Hannah Dragomanovich, Julie Sudduth-Klinger, Gina Vaccaro, Charles D Lopez, Margaret Tempero, Lisa M Coussens, and Lawrence Fong
Editorial. Overcoming implementation barriers in enhanced recovery using theory-based approaches., Walavan Sivakumar
Letter to the editor regarding "Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature"., Walavan Sivakumar and William T Couldwell
Enhanced recovery after brain tumor surgery: pilot protocol implementation in a large healthcare system., Walavan Sivakumar, Jian Guan, Jean-Philippe Langevin, Garni Barkhoudarian, Daniel F Kelly, and Neil A Martin
Treatment selection for patients with relapsed or refractory follicular lymphoma., Alan Z Skarbnik and Krish Patel
Impact of Fall Education to Nursing Staff on Oncology Patient Fall Rates, Danni Sloane
ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma., Holly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, Alexandra M Adams, Shu-Ching Chang, Gary Grunkemeier, Timothy J Vreeland, Ching-Wei D Tzeng, Matthew H Katz, and Daniel W Nelson
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma., Holly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, Alexandra M Adams, Shu-Ching Chang, Gary Grunkemeier, Timothy J Vreeland, Ching-Wei D Tzeng, Matthew H G Katz, and Daniel W Nelson
Allogeneic Chimeric Antigen Receptor T (CAR-T) cell Immunotherapy Targeting CD70 Tumor Antigen in Patients with Metastatic Clear Cell Renal Cell Carcinoma., S Srour, Brendan Curti, and See full list of authors in comments
Breast Cancer Vaccine Landscape. Stanton S. SABCS Annual Meeting; 2023 December 5; San Antonio, TX., Sasha Stanton
Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models, Sasha Stanton and See full list of authors in comments
Antigen Identification and Preventive Vaccine Development for Pre-Malignant Breast Lesions, SE Stanton
Clinical Trials: Patient Selection, Design, and Endpoints, SE Stanton
How does immunotherapy and your immune system work together to destroy cancer cells, SE Stanton
Primary Immunoprevention Strategies, SE Stanton
Rexinoids in Breast Cancer Prevention, SE Stanton
The Simplified Extraction of Atrial Tumor With Targeted Loop Electricity (SEATTLE) Procedure., Zachary L Steinberg, David Elison, Logan L Vincent, Donald Oxorn, and James M McCabe
Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer., Alan Su, Rodrigo Pedraza, and Hagen F Kennecke
Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial: Are We Overestimating the Quality of Our Resections?, Patricia Sylla, Mariana Berho, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Erin Moshier, Elisabeth Hain, Riva Letchinger, John Marks, Mark Whiteford, Elisabeth Mclemore, Justin Maykel, Karim Alavi, Karen Zaghiyan, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Alexandros Polydorides, and Steven Wexner
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results., Patricia Sylla, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Alexandros Polydorides, Mariana Berho, John Marks, Justin Maykel, Karim Alavi, Karen Zaghiyan, Mark Whiteford, Elisabeth Mclemore, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Erin Moshier, and Steven D Wexner
Biological functions of the Olig gene family in brain cancer and therapeutic targeting., Jenny Szu, Igor F Tsigelny, Alexandre Wojcinski, and Santosh Kesari
Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade., Shira Tabachnick-Cherny, Thomas Pulliam, Haroldo J Rodriguez, Xinyi Fan, Daniel S Hippe, Daniel C Jones, Ata S Moshiri, Kimberly S Smythe, Rima M Kulikauskas, Lisa Zaba, Kelly G Paulson, and Paul Nghiem
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848., Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine, Susan McNulty, Abraham Wu, Kevin L Du, Samantha A Seaward, Shelly X Bian, Raid Aljumaily, Anand Shivnani, Jeanna L Knoble, Todd S Crocenzi, Thomas A DiPetrillo, Kevin S Roof, Christopher H Crane, and Karyn A Goodman
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study., Krishnansu S Tewari, Michael W Sill, Michael J Birrer, Richard T Penson, Helen Huang, David H Moore, Lois M Ramondetta, Lisa M Landrum, Ana Oaknin, Thomas J Reid, Mario M Leitao, Helen E Michael, and Bradley J Monk
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma., Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, and Alyx B Porter
Abstract: 927 Streamlining Cancer Immunotherapy Research with the CRI IAtlas Data Resource and Web Portal, Vésteinn Thorsson, Carolina Heimann, Andrew Lamb, David L Gibbs, Dante Bortone, Sarah Dexheimer, Steven Vensko, Yooree Chae, Ilya Shmulevich, Benjamin Vincent, and James Eddy
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer., Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, and Seock-Ah Im
Harnessing the T-cell response against cancer mutations, E Tran
Neoantigen T-cell receptor therapy in solid cancer, E Tran
T-cell receptor gene therapy targeting HLA-II-restricted HPV antigens, E Tran
T-cell transfer therapy targeting oncogenic neoantigens, E Tran
Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives., Matthew Triplette, Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Giustini, Nicholas Murphy, Perrin E Romine, Bryan J Weiner, and Kristina Crothers
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC)., Angela D Trobaugh-Lotrario, Rudolf Maibach, Daniel C Aronson, Arun Rangaswami, Beate Häberle, Allison F O'Neill, Irene Schmid, Marc Ansari, Tomoro Hishiki, Sarangarajan Ranganathan, Rita Alaggio, Ronald R de Krijger, Yukichi Tanaka, Soo-Jin Cho, Christian Vokuhl, Rebecca Maxwell, Mark Krailo, Eiso Hiyama, Piotr Czauderna, Milton Finegold, James H Feusner, Marcio H Malogolowkin, Rebecka L Meyers, and Dolores Lopez-Terrada
Robot-assisted partial nephrectomy for complex renal tumors: Analysis of a large multi-institutional database., Burak Ucpinar, Jordan Miller Rich, Kennedy E Okhawere, Shirin Razdan, Osama Zaytoun, Laura Zuluaga, Indu Saini, Michael D Stifelman, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Simone Crivellero, Ahmed Mansour, Phillip M Pierorazio, and Ketan K Badani
The Impact of Prolonged Operative Time Associated with Minimally Invasive Colorectal Surgery: A Report from the Surgical Care Outcomes Assessment Program., Kenley R Unruh, Amir Bastawrous, Shalini Kanneganti, Jennifer A Kaplan, Ravi Moonka, Laila Rashidi, Arthur Sillah, and Vlad V Simianu
In Reply to Ward et al., Jayant S Vaidya, Max Bulsara, Frederik Wenz, Elena Sperk, Samuele Massarut, Michael Alvarado, Norman R Williams, Chris Brew-Graves, Marcelle Bernstein, Dennis Holmes, Lorenzo Vinante, Steffi Pigorsch, Steiner Lundgren, Valery Uhl, David Joseph, and Jeffrey S Tobias
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden., Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Els M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, and Noel F C C de Miranda
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial., Floris S Verheij, Dana M Omer, Hannah Williams, Sabrina T Lin, Li-Xuan Qin, James T Buckley, Hannah M Thompson, Jonathan B Yuval, Jin K Kim, Richard F Dunne, Jorge Marcet, Peter Cataldo, Blase Polite, Daniel O Herzig, David Liska, Samuel Oommen, Charles M Friel, Charles Ternent, Andrew L Coveler, Steven Hunt, Anita Gregory, Madhulika G Varma, Brian L Bello, Joseph C Carmichael, John Krauss, Ana Gleisner, José G Guillem, Larissa Temple, Karyn A Goodman, Neil H Segal, Andrea Cercek, Rona Yaeger, Garrett M Nash, Maria Widmar, Iris H Wei, Emmanouil P Pappou, Martin R Weiser, Philip B Paty, J Joshua Smith, Abraham J Wu, Marc J Gollub, Leonard B Saltz, and Julio Garcia-Aguilar
Location, location, location: spatial analysis of ultrahigh-plex immunofluorescence panel in head and neck cancer, Q Vu, Rom Leidner, Bernard Fox, and See full list of authors in comments
Accurate Prediction of 1p/19q Co-deletion in Oligodendrogliomas Using Comprehensive Genomic Profiling, J Wagner, Carlo Bifulco, Brian Piening, and See full list of authors in comments
A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer., Janet Wang, Jeanne Zheng, Elaine E Lee, Boris Aguilar, John Phan, Kawther Abdilleh, Ronald C Taylor, William Longabaugh, Bertil Johansson, Fredrik Mertens, Felix Mitelman, David Pot, and Thomas LaFramboise
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma., Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A Eyre, Chan Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John F Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, and Nirav N Shah
Cell Population Growth Kinetics in the Presence of Stochastic Heterogeneity of Cell Phenotype., Yue Wang, Joseph X Zhou, Edoardo Pedrini, Irit R Rubin, May Khalil, Roberto Taramelli, Hong Qian, and Sui Huang
Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype., Yue Wang, Joseph X Zhou, Edoardo Pedrini, Irit R Rubin, May Khalil, Roberto Taramelli, Hong Qian, and Sui Huang
NTRK Fusions and Concomitant Immune and Genomic Landscape Detected by DNA and RNA NGS in a Large Healthcare System, T Ward, Brian Piening, Carlo Bifulco, and See full list of authors in comments
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes. ASCO, Abst:3128, 6/2023., B Warnecke, Dave Hoon, and See full list of authors in comments
UCSB Pharmacology Colloquium, AD Weinberg
Using CD39/CD103 to Isolate Tumor-Reactive CD8 TIL: Bench to Bedside, AD Weinberg
T Cell Agonists. SITC Winter School Annual Meeting; 2023 January 18; Austin, TX., Andrew D Weinberg
Access to Lung Cancer Screening Among American Indians and Alaska Natives: A Qualitative Study., Allison C Welch, Sara M London, Candice Wilshire, Christopher R Gilbert, Dedra Buchwald, Gary Ferguson, Cole Allick, and Jed A Gorden
Adipocytes and ROS-Responsive hydrogels for Drug Delivery and Cancer Immunotherapy, D Wen
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma., Jason R Westin, Frederick L Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B Miklos, Matthew L Ulrickson, Miguel-Angel Perales, Umar Farooq, Luciano Wannesson, Lori Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Wulf, Patrick Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia T Snider, Paul Cheng, Christina To, Olalekan O Oluwole, and Anna Sureda
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer., Malinda T West, Shaun M Goodyear, Evthokia A Hobbs, Andy Kaempf, Thomas Kartika, Jessica Ribkoff, Brie Chun, and Zahi I Mitri
Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial., Candice L. Wilshire, Anee S Jackson, Eric Vallières, Adam J Bograd, Brian E Louie, Ralph W Aye, Alexander S Farivar, Peter T White, Christopher R Gilbert, and Jed A Gorden
Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?, Ana K Wilson, Kristel Lourdault, Tara Ostad, Stacey Stern, and Richard Essner
Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial, F TH Wu, HF Kennecke, and See all authors in comments
Life-threatening perioperative complications among older adults with spinal metastases: An analysis based on a nationwide inpatient sample of the US., Lien-Chen Wu, Yueh-Ying Hsieh, IChun Chen, and Chang-Jung Chiang
Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments, Mo Yang, Erin Mandal, Frank X Liu, Richard M O'Hara, Beth Lesher, and Rachel E Sanborn
Diagnostics of ovarian cancer via metabolite analysis and machine learning., Jerry Z Yao, Igor F Tsigelny, Santosh Kesari, and Valentina L Kouznetsova
Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia., William M Yashar, Brittany M Curtiss, Daniel J Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Julia E Maxson, and Theodore P Braun
Oncology Infusion Nurses' Personal Protective Equipment Use While Handling Hazardous Drugs, Deborah Yoon
Clinical Implications of TGFβ Inhibition in Radiotherapy (Panel 04), K Young
Panel 4 Discussant: Therapeutic Strategies for Immune Exclusion, K Young
The role of TGFβ in limiting anti-tumor therapeutic efficacy, K Young
Unlocking the Double-Edged Sword of TGF-β to Harness the Therapeutic Potential for Immuno-Oncology, K Young
Is There an Age Threshold for Active Surveillance in Highly Suspicious Subcentimeter Thyroid Nodules?, Stephanie Young and Melanie Goldfarb
Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies, H Yu, Brendan Curti, Will Redmond, and See full list of authors in comments
ASO Visual Abstract: Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease., Jennifer Q Zhang, Carlos Henrique Dos Anjos, Varadan Sevilimedu, Angelena Crown, Kimberly A Amoroso, Melissa L Pilewskie, Mark E Robson, and Mary L Gemignani
Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease., Jennifer Q Zhang, Carlos Henrique Dos Anjos, Varadan Sevilimedu, Angelena Crown, Kimberly A Amoroso, Melissa L Pilewskie, Mark E Robson, and Mary L Gemignani
Engineering a tunable micropattern-array assay to sort single extracellular vesicles and particles to detect RNA and protein in situ., Jingjing Zhang, Xilal Y Rima, Xinyu Wang, Luong T H Nguyen, Kristin Huntoon, Yifan Ma, Paola Loreto Palacio, Kim Truc Nguyen, Karunya Albert, Minh-Dao Duong-Thi, Nicole Walters, Kwang Joo Kwak, Min Jin Yoon, Hong Li, Jacob Doon-Ralls, Colin L Hisey, Daeyong Lee, Yifan Wang, Jonghoon Ha, Kelsey Scherler, Shannon Fallen, Inyoul Lee, Andre F Palmer, Wen Jiang, Setty M Magaña, Kai Wang, Betty Y S Kim, L James Lee, and Eduardo Reátegui
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls., Xiaoyu Zhao, Meiqi Yang, Jingyi Fan, Mei Wang, Yifan Wang, Na Qin, Meng Zhu, Yue Jiang, Olga Y Gorlova, Ivan P Gorlov, Demetrius Albanes, Stephen Lam, Adonina Tardón, Chu Chen, Gary E Goodman, Stig E Bojesen, Maria Teresa Landi, Mattias Johansson, Angela Risch, H-Erich Wichmann, Heike Bickeböller, David C Christiani, Gad Rennert, Susanne M Arnold, Paul Brennan, John K Field, Sanjay Shete, Loïc Le Marchand, Geoffrey Liu, Rayjean J Hung, Angeline S Andrew, Lambertus A Kiemeney, Shanbeh Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil E Caporaso, Penella J Woll, Philip Lazarus, Matthew B Schabath, Melinda C Aldrich, Alpa V Patel, Michael P A Davies, Hongxia Ma, Guangfu Jin, Zhibin Hu, Christopher I Amos, Hongbing Shen, and Juncheng Dai
Amivantamab plus Chemotherapy in NSCLC with, Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, Baogang Liu, Luis Paz-Ares, Susanna Cheng, Satoru Kitazono, Muthukkumaran Thiagarajan, Jonathan W Goldman, Joshua K Sabari, Rachel E Sanborn, Aaron S Mansfield, Jen-Yu Hung, Michael Boyer, Sanjay Popat, Josiane Mourão Dias, Enriqueta Felip, Margarita Majem, Mahmut Gumus, Sang-We Kim, Akira Ono, John Xie, Archan Bhattacharya, Trishala Agrawal, S Martin Shreeve, Roland E Knoblauch, Keunchil Park, and Nicolas Girard
Submissions from 2022
Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program., Amit S Adhikari, Teresa Sullivan, Rhishikesh Bargaje, Lucy Lu, T Norene O'Sullivan, Yurong Song, and Terry Van Dyke
